Denali Therapeutics DNLI
$18.45 +$0.25 (+1.37%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.45 0.00%
Open$17.97
Prev close$18.20
Day range$17.92 – $18.85
Volume2.63M
Market cap$2.96B
P/E (TTM)–
Dividend yield–
Earnings
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 3 Nov 2026 | After Market | ±15.8% | +7.76% | Within range |
| 2026/Q2 | 6 Aug 2026 | After Market | ±11.3% | +0.40% | Within range |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$17.78M
Operating profit-$126.75M+7.8% YoY
Net profit$70.13M+155.3% YoY
Diluted EPS$0.37+150.0% YoY
Free cash flow-$125.65M-18.6% YoY
Operating cash flow-$117.44M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin98.9%
Operating margin-2,488.1%
Net margin-1,470.5%
Return on equity-33.9%
Return on assets-27.2%
Return on invested capital-35.1%
Current ratio6.21
Liabilities / assets26.2%
Cash & investments$516.20M
Total debt$19.28M
Net cash (debt)$496.92M
No comments yet — be the first to weigh in on DNLI.
Sign in to join the discussion.